Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$27.12 - $45.97 $536,976 - $910,206
-19,800 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$26.16 - $63.5 $39,240 - $95,250
1,500 Added 8.2%
19,800 $910,000
Q4 2019

Feb 14, 2020

BUY
$46.96 - $61.67 $859,368 - $1.13 Million
18,300 New
18,300 $1.61 Million
Q3 2019

Nov 14, 2019

SELL
$59.47 - $93.1 $1.08 Million - $1.69 Million
-18,200 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$75.84 - $105.21 $371,616 - $515,528
-4,900 Reduced 21.21%
18,200 $2.32 Million
Q1 2019

May 15, 2019

BUY
$64.44 - $104.11 $657,288 - $1.06 Million
10,200 Added 79.07%
23,100 $3.63 Million
Q4 2018

Feb 12, 2019

BUY
$59.1 - $93.26 $88,650 - $139,890
1,500 Added 13.16%
12,900 $1.28 Million
Q3 2018

Nov 13, 2018

SELL
$88.86 - $117.49 $133,290 - $176,235
-1,500 Reduced 11.63%
11,400 $1.66 Million
Q2 2018

Aug 07, 2018

SELL
$99.64 - $127.59 $39,856 - $51,036
-400 Reduced 3.01%
12,900 $2.03 Million
Q1 2018

May 09, 2018

SELL
$105.8 - $150.94 $613,640 - $875,452
-5,800 Reduced 30.37%
13,300 $2.27 Million
Q4 2017

Feb 14, 2018

SELL
$81.25 - $130.7 $487,500 - $784,199
-6,000 Reduced 23.9%
19,100 $3.4 Million
Q3 2017

Nov 13, 2017

BUY
$57.74 - $91.42 $173,220 - $274,260
3,000 Added 13.57%
25,100 $3.45 Million
Q2 2017

Aug 14, 2017

BUY
N/A
22,100
22,100 $2.32 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.